STE · 10-Q · 2026Q2 · Full report
Geographic Market Commentary
STERIS plc · 2026-08-07 · Importance 52 · Surprise 30 · No source text
United States revenue increased 6.3% to $1,090.6 million, reflecting growth in service, consumable, and capital equipment revenues. Ireland revenue increased 28.7% to $29.0 million, with growth across service, capital equipment, and consumable revenues. Revenue from other foreign locations increased 8.8% to $373.2 million, reflecting growth across all geographic regions. The company’s revenues are primarily tied to healthcare, medical device, and pharmaceutical customers worldwide.
Key facts
- United States revenues for the three months ended June 30, 2026: $1,090.6 million, compared to $1,025.6 million for the three months ended June 30, 2025 (6.3% increase). source
- Other foreign revenues for the three months ended June 30, 2026: $373.2 million, compared to $342.9 million for the three months ended June 30, 2025 (8.8% increase). source
- Ireland revenues for the three months ended June 30, 2026: $29.0 million, compared to $22.5 million for the three months ended June 30, 2025 (28.7% increase). source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +4.3% | United States revenues for the three months ended June 30, 2026: $1,090.6 million, compared to $1,025.6 million for the three months ended… |
| revenue | positive | realized | +2.0% | Other foreign revenues for the three months ended June 30, 2026: $373.2 million, compared to $342.9 million for the three months ended… |